BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

564 related articles for article (PubMed ID: 9515024)

  • 21. E2F-1 overexpression in cardiomyocytes induces downregulation of p21CIP1 and p27KIP1 and release of active cyclin-dependent kinases in the presence of insulin-like growth factor I.
    von Harsdorf R; Hauck L; Mehrhof F; Wegenka U; Cardoso MC; Dietz R
    Circ Res; 1999 Jul; 85(2):128-36. PubMed ID: 10417394
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Impairment of rat postnatal lung alveolar development by glucocorticoids: involvement of the p21CIP1 and p27KIP1 cyclin-dependent kinase inhibitors.
    Corroyer S; Schittny JC; Djonov V; Burri PH; Clement A
    Pediatr Res; 2002 Feb; 51(2):169-76. PubMed ID: 11809910
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The cyclin-dependent kinase inhibitor p27(Kip1) induces N-terminal proteolytic cleavage of cyclin A.
    Bastians H; Townsley FM; Ruderman JV
    Proc Natl Acad Sci U S A; 1998 Dec; 95(26):15374-81. PubMed ID: 9860976
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Differential and dramatic changes of cyclin-dependent kinase activities in cardiomyocytes during the neonatal period.
    Kang MJ; Koh GY
    J Mol Cell Cardiol; 1997 Jul; 29(7):1767-77. PubMed ID: 9236132
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Different expression patterns of p27 and p57 proteins in benign and malignant melanocytic neoplasms and in cultured human melanocytes.
    Curry JL; Richards HW; Huttenbach YT; Medrano EE; Reed JA
    J Cutan Pathol; 2009 Feb; 36(2):197-205. PubMed ID: 18647205
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cooperation of p27(Kip1) and p18(INK4c) in progestin-mediated cell cycle arrest in T-47D breast cancer cells.
    Swarbrick A; Lee CS; Sutherland RL; Musgrove EA
    Mol Cell Biol; 2000 Apr; 20(7):2581-91. PubMed ID: 10713180
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Induction of anergy in Th1 cells associated with increased levels of cyclin-dependent kinase inhibitors p21Cip1 and p27Kip1.
    Jackson SK; DeLoose A; Gilbert KM
    J Immunol; 2001 Jan; 166(2):952-8. PubMed ID: 11145672
    [TBL] [Abstract][Full Text] [Related]  

  • 28. p57KIP2: "Kip"ing the cell under control.
    Pateras IS; Apostolopoulou K; Niforou K; Kotsinas A; Gorgoulis VG
    Mol Cancer Res; 2009 Dec; 7(12):1902-19. PubMed ID: 19934273
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Immunohistochemical examination of the INK4 and Cip inhibitors in the rat neonatal cerebellum: cellular localization and the impact of protein calorie malnutrition.
    Shambaugh GE; Haines GK; Koch A; Lee EJ; Zhou Jn; Pestell R
    Brain Res; 2000 Feb; 855(1):11-22. PubMed ID: 10650125
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Altered expression of cell cycle proteins and prolonged duration of cardiac myocyte hyperplasia in p27KIP1 knockout mice.
    Poolman RA; Li JM; Durand B; Brooks G
    Circ Res; 1999 Jul; 85(2):117-27. PubMed ID: 10417393
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Development of mice without Cip/Kip CDK inhibitors.
    Tateishi Y; Matsumoto A; Kanie T; Hara E; Nakayama K; Nakayama KI
    Biochem Biophys Res Commun; 2012 Oct; 427(2):285-92. PubMed ID: 23000166
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Involvement of p21(WAF1/Cip1) and p27(Kip1) in intestinal epithelial cell differentiation.
    Tian JQ; Quaroni A
    Am J Physiol; 1999 Jun; 276(6):C1245-58. PubMed ID: 10362586
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Inhibition of the phosphoinositide 3-kinase pathway induces a senescence-like arrest mediated by p27Kip1.
    Collado M; Medema RH; Garcia-Cao I; Dubuisson ML; Barradas M; Glassford J; Rivas C; Burgering BM; Serrano M; Lam EW
    J Biol Chem; 2000 Jul; 275(29):21960-8. PubMed ID: 10791951
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Role of cyclin-dependent kinase inhibitors in the growth arrest at senescence in human prostate epithelial and uroepithelial cells.
    Schwarze SR; Shi Y; Fu VX; Watson PA; Jarrard DF
    Oncogene; 2001 Dec; 20(57):8184-92. PubMed ID: 11781834
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Antitumour effect of cyclin-dependent kinase inhibitors (p16(INK4A), p18(INK4C), p19(INK4D), p21(WAF1/CIP1) and p27(KIP1)) on malignant glioma cells.
    Komata T; Kanzawa T; Takeuchi H; Germano IM; Schreiber M; Kondo Y; Kondo S
    Br J Cancer; 2003 Apr; 88(8):1277-80. PubMed ID: 12698196
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The multiple roles of the cyclin-dependent kinase inhibitory protein p57(KIP2) in cerebral cortical neurogenesis.
    Tury A; Mairet-Coello G; DiCicco-Bloom E
    Dev Neurobiol; 2012 Jun; 72(6):821-42. PubMed ID: 22076965
    [TBL] [Abstract][Full Text] [Related]  

  • 37. p27Kip1 and p57Kip2 regulate proliferation in distinct retinal progenitor cell populations.
    Dyer MA; Cepko CL
    J Neurosci; 2001 Jun; 21(12):4259-71. PubMed ID: 11404411
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Magnesium deficiency suppresses cell cycle progression mediated by increase in transcriptional activity of p21(Cip1) and p27(Kip1) in renal epithelial NRK-52E cells.
    Ikari A; Sawada H; Sanada A; Tonegawa C; Yamazaki Y; Sugatani J
    J Cell Biochem; 2011 Dec; 112(12):3563-72. PubMed ID: 21780161
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Differential expression of cyclin-dependent kinase inhibitors in human glomerular disease: role in podocyte proliferation and maturation.
    Shankland SJ; Eitner F; Hudkins KL; Goodpaster T; D'Agati V; Alpers CE
    Kidney Int; 2000 Aug; 58(2):674-83. PubMed ID: 10916090
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Reduced expression of the CDK inhibitor p27(KIP1) in rat two-stage bladder carcinogenesis and its association with expression profiles of p21(WAF1/Cip1) and p53.
    Lee CC; Ichihara T; Yamamoto S; Wanibuchi H; Sugimura K; Wada S; Kishimoto T; Fukushima S
    Carcinogenesis; 1999 Sep; 20(9):1697-708. PubMed ID: 10469613
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 29.